Cucurbitacin: Ancient Compound Shedding New Light on Cancer Treatment
Cucurbitacins and their derivatives are triterpenoids found in medicinal plants known for their diverse pharmacological and biological activities, including anticancer effects, throughout human history. Although initial attention to cucurbitacin as a potential anticancer drug withered for decades, r...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/tsw.2010.44 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850160226694594560 |
|---|---|
| author | Dhong Hyun Lee Gabriela B. Iwanski Nils H. Thoennissen |
| author_facet | Dhong Hyun Lee Gabriela B. Iwanski Nils H. Thoennissen |
| author_sort | Dhong Hyun Lee |
| collection | DOAJ |
| description | Cucurbitacins and their derivatives are triterpenoids found in medicinal plants known for their diverse pharmacological and biological activities, including anticancer effects, throughout human history. Although initial attention to cucurbitacin as a potential anticancer drug withered for decades, recent discoveries showing that cucurbitacin is a strong STAT3 (Signal Transducers and Activators of Transcription-3) inhibitor have reclaimed the attention of the drug industry one more time. There is increasing evidence showing that some cucurbitacins not only inhibit the JAK-STAT pathway, but also affect other signaling pathways, such as the MAPK pathway, which are also known to be important for cancer cell proliferation and survival. Moreover, some reports have shown the synergistic effect of cucurbitacins with known chemotherapeutic agents, such as doxorubicin and gemcitabine. In this review, we will summarize the recent discoveries regarding molecular mechanisms of action of cucurbitacins in human cancer cells and discuss the possibilities of cucurbitacin as a future anticancer drug in clinical settings. |
| format | Article |
| id | doaj-art-b42aeaef31b7488db773dd579015bd01 |
| institution | OA Journals |
| issn | 1537-744X |
| language | English |
| publishDate | 2010-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-b42aeaef31b7488db773dd579015bd012025-08-20T02:23:12ZengWileyThe Scientific World Journal1537-744X2010-01-011041341810.1100/tsw.2010.44Cucurbitacin: Ancient Compound Shedding New Light on Cancer TreatmentDhong Hyun Lee0Gabriela B. Iwanski1Nils H. Thoennissen2Division of Hematology and Oncology, Cedars-Sinai Medical Center, School of Medicine, University of California, Los Angeles, CA, USADivision of Hematology and Oncology, Cedars-Sinai Medical Center, School of Medicine, University of California, Los Angeles, CA, USADivision of Hematology and Oncology, Cedars-Sinai Medical Center, School of Medicine, University of California, Los Angeles, CA, USACucurbitacins and their derivatives are triterpenoids found in medicinal plants known for their diverse pharmacological and biological activities, including anticancer effects, throughout human history. Although initial attention to cucurbitacin as a potential anticancer drug withered for decades, recent discoveries showing that cucurbitacin is a strong STAT3 (Signal Transducers and Activators of Transcription-3) inhibitor have reclaimed the attention of the drug industry one more time. There is increasing evidence showing that some cucurbitacins not only inhibit the JAK-STAT pathway, but also affect other signaling pathways, such as the MAPK pathway, which are also known to be important for cancer cell proliferation and survival. Moreover, some reports have shown the synergistic effect of cucurbitacins with known chemotherapeutic agents, such as doxorubicin and gemcitabine. In this review, we will summarize the recent discoveries regarding molecular mechanisms of action of cucurbitacins in human cancer cells and discuss the possibilities of cucurbitacin as a future anticancer drug in clinical settings.http://dx.doi.org/10.1100/tsw.2010.44 |
| spellingShingle | Dhong Hyun Lee Gabriela B. Iwanski Nils H. Thoennissen Cucurbitacin: Ancient Compound Shedding New Light on Cancer Treatment The Scientific World Journal |
| title | Cucurbitacin: Ancient Compound Shedding New Light on Cancer Treatment |
| title_full | Cucurbitacin: Ancient Compound Shedding New Light on Cancer Treatment |
| title_fullStr | Cucurbitacin: Ancient Compound Shedding New Light on Cancer Treatment |
| title_full_unstemmed | Cucurbitacin: Ancient Compound Shedding New Light on Cancer Treatment |
| title_short | Cucurbitacin: Ancient Compound Shedding New Light on Cancer Treatment |
| title_sort | cucurbitacin ancient compound shedding new light on cancer treatment |
| url | http://dx.doi.org/10.1100/tsw.2010.44 |
| work_keys_str_mv | AT dhonghyunlee cucurbitacinancientcompoundsheddingnewlightoncancertreatment AT gabrielabiwanski cucurbitacinancientcompoundsheddingnewlightoncancertreatment AT nilshthoennissen cucurbitacinancientcompoundsheddingnewlightoncancertreatment |